TY - JOUR
T1 - Differential Effects of Diazepam and Pentobarbital on Mood and Behavior
AU - Griffiths, Roland R.
AU - Bigelow, George E.
AU - Liebson, Ira
PY - 1983/8
Y1 - 1983/8
N2 - The effects of administering moderately high doses of diazepam and pentobarbital sodium for five consecutive days to subjects with histories of sedative drug abuse were examined. The two drugs produced similar dose-related effects on psychomotor performance, daytime sleeping, and ratings of magnitude of drug effects. Diazepam, but not pentobarbital, produced dose-related decreases in staff ratings of subjects’ mood and social interactions and increases in staff ratings of subjects’ hostility, complaining, and unusual behavior. During the placebo washout periods that followed drug administration, diazepam, but not pentobarbital, was associated with carry-over effects. The diazepam-produced deterioration in mood and social behavior was a subtle effect observed in a population for which usual therapeutic indications were lacking and at higher than usual therapeutic doses. The syndrome may, however, occur with long-term diazepam use or misuse in therapeutic settings and, hence, warrants clinical awareness in monitoring the course of treatment.
AB - The effects of administering moderately high doses of diazepam and pentobarbital sodium for five consecutive days to subjects with histories of sedative drug abuse were examined. The two drugs produced similar dose-related effects on psychomotor performance, daytime sleeping, and ratings of magnitude of drug effects. Diazepam, but not pentobarbital, produced dose-related decreases in staff ratings of subjects’ mood and social interactions and increases in staff ratings of subjects’ hostility, complaining, and unusual behavior. During the placebo washout periods that followed drug administration, diazepam, but not pentobarbital, was associated with carry-over effects. The diazepam-produced deterioration in mood and social behavior was a subtle effect observed in a population for which usual therapeutic indications were lacking and at higher than usual therapeutic doses. The syndrome may, however, occur with long-term diazepam use or misuse in therapeutic settings and, hence, warrants clinical awareness in monitoring the course of treatment.
UR - http://www.scopus.com/inward/record.url?scp=0020576342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020576342&partnerID=8YFLogxK
U2 - 10.1001/archpsyc.1983.01790070055007
DO - 10.1001/archpsyc.1983.01790070055007
M3 - Article
C2 - 6870483
AN - SCOPUS:0020576342
SN - 2168-622X
VL - 40
SP - 865
EP - 873
JO - JAMA Psychiatry
JF - JAMA Psychiatry
IS - 8
ER -